FDA proposes new path to 510(k) clearance

The U.S. Food and Drug Administration (FDA) has proposed a new pathway for...Read more on AuntMinnie.comRelated Reading: FDA authorizes ACR to accredit DBT devices FDA releases update on breast implant lymphoma risk FDA: Brain coils may cause artifacts on MRA images FDA clears blood test to assist concussion evaluation FDA updates policy for nixing 510(k) submissions
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news

Related Links:

Learning about concussion diagnosis and management is important for all individuals who will be taking care of young athletes. There are about 1.7million reported concussions per year, and, of these, about 20% are sports related. There are risks in all spo...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
Sports-related concussion is associated with a range of short-term functional deficits that are commonly thought to recover within a two-week post-injury period for most, but certainly not all, people. Resting state electroencephalography (rs-EEG) may prov...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news
This study examined the feasibi...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news
The SATB1 protein has been the focus of two recent studies of cutaneous T-cell lymphomas. Fredholm et  al. observed a stage-related decrease of SATB1 expression in epidermotropic cutaneous T-cell lymphomas. SATB1 was negatively regulated by STAT5 through microRNA-155, which in turn triggered enhanced expression of T helper type 2 cytokines such as IL-5 and IL-9. In parallel, Sun et al. found that SATB1 expression was up-regulated by promoter demethylation in a subset of cutaneous anaplastic lymphoma and was associated with T helper type 17 polarization in patients with better therapeutic responses.
Source: Journal of Investigative Dermatology - Category: Dermatology Authors: Tags: Commentary Source Type: research
Conclusion: Tissue biopsy is needed to exclude other differential diagnoses, whereas a multidisciplinary approach is needed to manage PTL.Case Rep Oncol 2018;11:505 –510
Source: Case Reports in Oncology - Category: Cancer & Oncology Source Type: research
Acute kidney injury (AKI) is a common complication in cancer patients and occurs in up to 30% of patients during their disease course. Multiple myeloma, leukemia/lymphoma, renal cell carcinoma, and hematopoietic stem cell transplantation are commonly associated with the development of AKI.07/19/2018
Source: Kidney Cancer Association - Category: Urology & Nephrology Source Type: news
Conditions:   Lymphoma;   Lymphoma, B-Cell;   Lymphoma, Large B-Cell, Diffuse Intervention:   Drug: Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy Sponsors:   Second Affiliated Hospital of Xi'an Jiaotong University;   Nanjing Legend Biotech Co. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Relapsed Angioimmunoblastic T-Cell Lymphoma;   Refractory Angioimmunoblastic T-cell Lymphoma Interventions:   Drug: Oral azacitidine;   Drug: Romidepsin;   Drug: Bendamustine;   Drug: Gemcitabine Sponsors:   The Lymphoma Academic Research Organisation;   Celgene Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
OBJECTIVE: The purpose of this study was to examine the influence of a brief exercise protocol on Sport Concussion Assessment Tool-Third Edition (SCAT3) performance in amateur women athletes. DESIGN: Cross-over repeated-measures design. SETTING: Of...
Source: SafetyLit - Category: International Medicine & Public Health Tags: TBI Source Type: news
Publication date: Available online 25 June 2018Source: Clinical Lymphoma Myeloma and LeukemiaAuthor(s): Avi Leader, Noam Benyamini, Anat Gafter-Gvili, Juliet Dreyer, Bronya Calvarysky, Alina Amitai, Osnat Yarchovsky-Dolberg, Giora Sharf, Eric Tousset, Opher Caspi, Martin Ellis, Itai Levi, Sabina De Geest, Pia RaananiAbstractBackgroundNonadherence to tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia (CML) has been associated with inferior outcomes. Scarce evidence exists on the effectiveness of adherence-enhancing interventions. The present pilot study evaluated the feasibility and effectiveness of an interventi...
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
More News: Brain | Concussion | Food and Drug Administration (FDA) | Lymphoma | Neurology | Plastic Surgery